Saad Z. Usmani, Thierry Facon, Vania Hungria, Nizar Jacques J. Bahlis, Christopher P. Venner, Marc Justin Braunstein, Ludek Pour, Josep Marti, Supratik Basu, Yael C. Cohen, Kenshi Suzuki, Cyrille Hulin, Sebastian Grosicki, Meral Beksac, Angelo Maiolino, Jaclyn Stanziola, Lorena Lopez-Masi, Matteo Loi, Melissa Rowe, Sonja Zweegman. "Daratumumab plus bortezomib, lenalidomide, and dexamethasone (DVRd) in patients (pts) with newly diagnosed multiple myeloma (NDMM): Final analysis of transplant-ineligible (TIE) pts in the phase 3 CEPHEUS study.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.7513